文章摘要
高压氧联合肌电生物反馈对急性脑梗死恢复期脑氧代谢、神经功能和肢体功能的影响
Influences of hyperbaric oxygen combined with electromyographic biofeedback on cerebral oxygen metabolism, nerve function and limb function in the recovery period of acute cerebral infarction
投稿时间:2024-07-15  修订日期:2024-07-15
DOI:
中文关键词: 高压氧  肌电生物反馈  急性脑梗死恢复期  脑氧代谢  神经功能  肢体功能
英文关键词: hyperbaric oxygen  Electromyographic biofeedback therapy  Acute cerebral infarction in the recovery period  Brain oxygen metabolism  Nerve function  Limb function
基金项目:
作者单位邮编
黎飞 襄阳市中心医院 44100
刘佩军 襄阳市中心医院 44100
摘要点击次数: 49
全文下载次数: 0
中文摘要:
      目的:探究高压氧联合肌电生物反馈对急性脑梗死恢复期脑氧代谢、神经功能、肢体功能的影响。 方法:依据随机抽样法将2021年1月至2022年12月期间于本院治疗的106例患者分为对照组(53例)、联合组(53例)。两组均根据患者病情给予常规治疗,对照组在常规治疗基础上施以肌电生物反馈疗法治疗急性脑梗死,联合组在常规治疗基础上采用高压氧联合肌电生物反馈进行治疗,对比两组治疗前后患者临床疗效、脑氧代谢指标(CaO2、D(a-jy)O2、CERO2)水平、神经功能缺损评分量表(NIHSS)评分、Fugl-Meyer评定表(FMA)评分及不良反应发生率。 结果:联合组患者治疗总有效率为90.57%,显著高于对照组的79.25%(P<0.05);联合组患者不良反应总发生率为11.32%,对照组不良反应总发生率为7.55%,组间比较差异无显著性(P>0.05);两组治疗前CaO2、D(a-jy)O2、CERO2水平比较无明显差异(P>0.05);治疗后两组CaO2、D(a-jy)O2、CERO2水平显著下降(P<0.05),且联合组下降程度明显高于对照组(P<0.05),治疗后CaO2水平比较,差异无统计学意义(P>0.05);治疗后联合组NIHSS评分显著低于对照组(P<0.05);FMA评分显著高于对照组(P<0.05)。结论:高压氧联合肌电生物反馈治疗急性脑梗死恢复期患者的疗效显著,可调节脑氧代谢水平,改善神经缺损功能,有效促进肢体恢复,且安全性较高。
英文摘要:
      Objective: To explore the influences of hyperbaric oxygen combined with electromyography biofeedback on cerebral oxygen metabolism, nerve function and limb function during the recovery period of acute cerebral infarction. Methods: A total of 106 patients who were treated in our hospital from January 2021 to December 2022 were grouped into control group (53 cases) and combined group (53 cases) according to random sampling method. Both groups were given conventional treatment according to the patients' conditions. The control group was treated with electromyographic biofeedback therapy on the basis of conventional treatment for acute cerebral infarction, and the combined group was treated with hyperbaric oxygen combined with myoelectric biofeedback on the basis of conventional treatment. The clinical efficacy, brain oxygen metabolism index [CaO2, D(a-jy)O2, CERO2] level, National Institute of Health stroke scale (NIHSS) score, Fugl-Meyer rating scale (FMA) score and adverse reaction rate were compared between the two groups before and after treatment. Results: The total effective rate of the combined group was 90.57%, which was obviously higher than 79.25% of the control group (P<0.05); the total incidence of adverse reactions in the combined group was 11.32%, the total incidence of adverse reactions in the control group was 7.55%, and there was no obvious difference between the groups (P>0.05); there was no obvious difference in the levels of CaO2, D(a-jy)O2 and CERO2 between the two groups before treatment (P>0.05); after treatment, the levels of CaO2, D(a-jy)O2 and CERO2 in the two groups decreased obviously (P<0.05), the decrease degrees of the combined group were obviously higher than those of the control group (P<0.05), while there was no obvious difference in CaO2 between the two groups after treatment (P>0.05); there was no obvious difference in NIHSS score between the two groups before treatment (P>0.05), after treatment, the NIHSS score of the two groups decreased obviously (P<0.05), the decrease of the study group was more obvious than that of the control group (P<0.05); there was no obvious difference in FMA scores between the two groups before treatment (P>0.05), after treatment, the FMA score of the two groups increased obviously (P<0.05), the degree of increase in the study group was higher than that in the control group (P<0.05). Conclusion: Hyperbaric oxygen combined with myoelectric biofeedback has significant efficacy in the treatment of patients in the convalescent stage of acute cerebral infarction, which can adjust the level of cerebral oxygen metabolism, improve nerve defect function, effectively promote limb recovery, and has high safety.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭